A Pilot Study of Cord Blood-Derived Natural Killer Cells As Maintenance Therapy After Autologous Hematopoietic Stem Cell Transplantation

Investigators expanded cord blood-derived natural killer (CB-NK) cells ex vivo from random donors and investigated the feasibility and efficacy of repeated infusions CB-NK cells as maintenance therapy after autologous hematopoietic stem cell transplantation.